Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation

被引:48
|
作者
Alam, S. Munir [1 ]
Liao, Hua-Xin [1 ]
Dennison, S. Moses [1 ]
Jaeger, Frederick [1 ]
Parks, Robert [1 ]
Anasti, Kara [1 ]
Foulger, Andrew [1 ]
Donathan, Michele [1 ]
Lucas, Judith [1 ]
Verkoczy, Laurent [1 ]
Nicely, Nathan [1 ]
Tomaras, Georgia D. [1 ]
Kelsoe, Garnett [1 ,2 ,3 ,4 ]
Chen, Bing [5 ]
Kepler, Thomas B. [1 ,6 ]
Haynes, Barton F. [1 ,2 ,3 ,4 ]
机构
[1] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA
[2] Duke Univ, Dept Med, Durham, NC 27710 USA
[3] Duke Univ, Dept Surg, Durham, NC 27710 USA
[4] Duke Univ, Dept Immunol, Durham, NC 27710 USA
[5] Harvard Univ, Sch Med, Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA
[6] Duke Univ, Ctr Computat Immunol, Durham, NC 27710 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
CHAIN VARIABLE-REGION; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODY; MEMBRANE; 2F5; GENE; 4E10; RESPONSES; AFFINITY; BINDING;
D O I
10.1128/JVI.05680-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic factors, as well as antigenic stimuli, can influence antibody repertoire formation. Moreover, the affinity of antigen for unmutated naive B cell receptors determines the threshold for activation of germinal center antibody responses. The gp41 2F5 broadly neutralizing antibody (bNAb) uses the V(H)2-5 gene, which has 10 distinct alleles that use either a heavy-chain complementarity-determining region 2 (HCDR2) aspartic acid (D-H54) or an HCDR2 asparagine (N-H54) residue. The 2F5 HCDR2 D-H54 residue has been shown to form a salt bridge with gp41 K-665; the V(H)2-5 germ line allele variant containing N-H54 cannot do so and thus should bind less avidly to gp41. Thus, the induction of 2F5 bNAb is dependent on both genetic and structural factors that could affect antigen affinity of unmutated naive B cell receptors. Here, we studied allelic variants of the V(H)2-5 inferred germ line forms of the HIV-1 gp41 bNAb 2F5 for their antigen binding affinities to gp41 linear peptide and conformational protein antigens. Both V(H)2-5 2F5 inferred germ line variants bound to gp41 peptides and protein, including the fusion intermediate protein mimic, although more weakly than the mature 2F5 antibody. As predicted, the affinity of the N-H54 variant for fusion-intermediate conformation was an order of magnitude lower than that of the D-H54 V(H)2-5 germ line antibody, demonstrating that allelic variants of 2F5 germ line antibodies differentially bind to gp41. Thus, these data demonstrate a genetically determined trait that may affect host responses to HIV-1 envelope epitopes recognized by broadly neutralizing antibodies and has implications for unmutated ancestor-based immunogen design.
引用
收藏
页码:11725 / 11731
页数:7
相关论文
共 50 条
  • [21] Erratum: Capture of an early fusion-active conformation of HIV-1 gp41
    Rika Furuta
    Carl Wild
    Yongkai Weng
    Carol Weiss
    Nature Structural Biology, 1998, 5 : 612 - 612
  • [22] Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
    Scharf, Louise
    West, Anthony P., Jr.
    Gao, Han
    Lee, Terri
    Scheid, Johannes F.
    Nussenzweig, Michel C.
    Bjorkman, Pamela J.
    Diskin, Ron
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (15) : 6049 - 6054
  • [23] Structural Basis for HIV-1 gp120 Recognition by a Germ-line Version of a Broadly Neutralizing Antibody
    Scharf, L.
    West, A. P.
    Scheid, J. F.
    Nussenzweig, M. C.
    Bjorkman, P. J.
    Diskin, R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A11 - A12
  • [24] Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
    Bianchi, Elisabetta
    Joyce, Joseph G.
    Miller, Michael D.
    Finnefrock, Adam C.
    Liang, Xiaoping
    Finotto, Marco
    Ingallinella, Paolo
    McKenna, Philip
    Citron, Michael
    Ottinger, Elizabeth
    Hepler, Robert W.
    Hrin, Renee
    Nahas, Deborah
    Wu, Chengwei
    Montefiori, David
    Shiver, John W.
    Pessi, Antonello
    Kim, Peter S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (23) : 10655 - 10660
  • [25] Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
    Caulfield, Michael J.
    Dudkin, Vadim Y.
    Ottinger, Elizabeth A.
    Getty, Krista L.
    Zuck, Paul D.
    Kaufhold, Robin M.
    Hepler, Robert W.
    McGaughey, Georgia B.
    Citron, Michael
    Hrin, Renee C.
    Wang, Ying-Jie
    Miller, Michael D.
    Joyce, Joseph G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (52) : 40604 - 40611
  • [26] Neutralizing Antibody to HIV-1 gp41 MPER Alters Recognition Properties of the Infectious Spike
    Kim, A.
    Leaman, D.
    Zwick, M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A165 - A165
  • [27] RETRACTED: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER (Retracted Article)
    Han, D.
    Habte, H.
    Qin, Y.
    Takamoto, K.
    LaBranche, C.
    Montefiori, D.
    Cho, M. W.
    RETROVIROLOGY, 2012, 9
  • [28] Conformational Changes of HIV-1 gp41 Membrane Proximal Ectodomain Region Induced by Broadly Neutralizing Antibodies
    Song, Likai
    Sun, Zhen-Yu J.
    Coleman, Kate
    Oh, Kyoung Joon
    Wagner, Gerhard
    Reinherz, Ellis
    Kim, Mikyung
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 336A - 336A
  • [29] HIV-1 Envelope Protein gp41: An NMR Study of Dodecyl Phosphocholine Embedded gp41 Reveals a Dynamic Prefusion Intermediate Conformation
    Lakomek, Nils-Alexander
    Kaufman, Joshua D.
    Stah, Stephen J.
    Wingfield, Paul T.
    STRUCTURE, 2014, 22 (09) : 1311 - 1321
  • [30] Amphipathic Properties of HIV-1 gp41 Fusion Inhibitors
    Gochin, Miriam
    Zhou, Guangyan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (24) : 3022 - 3032